Maki Komiyama

National Hospital Organization, Kyoto Medical Center, Japan

Articles by Maki Komiyama

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

Maki Komiyama, Koji Hasegawa, Akira Matsumori, et al

Published:

Citation: European Cardiology Review 2020;15:e49.

DOI:

https://doi.org/10.15420/ecr.2020.17
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019’

Maki Komiyama, Koji Hasegawa,

Published:

Citation: European Cardiology Review 2020;15:e55.

DOI:

https://doi.org/10.15420/ecr.2020.25
Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness

Maki Komiyama, Koji Hasegawa,

Published:

Citation: European Cardiology Review 2020;15:e58.

DOI:

https://doi.org/10.15420/ecr.2020.24
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic

Maki Komiyama, Koji Hasegawa,

Published:

Citation: European Cardiology Review 2020;15:e16.

DOI:

https://doi.org/10.15420/ecr.2020.11
Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence

Koji Hasegawa, Maki Komiyama, Yuko Takahashi, et al

Citation: European Cardiology Review 2019;14(1):60–1

DOI:

https://doi.org/10.15420/ecr.2019.4.2
ISCP Guest Editorial: Cardiovascular Disease Prevention in Diabetes

Maki Komiyama, Koji Hasegawa,

Citation: European Cardiology Review 2018;13(1):21–2.

DOI:

https://doi.org/10.15420/ecr.13.1.1.GE1
Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Maki Komiyama, Hiromichi Wada, Hajime Yamakage, et al

Citation: European Cardiology Review 2017;12(2):96.

DOI:

https://doi.org/10.15420/ecr.2017:23:5
Analysis of Factors Associated with Smoking Relapse

Sayaka Shimada, Maki Komiyama, Hiromichi Wada, et al

Citation: European Cardiology Review 2017;12(2):111.

DOI:

https://doi.org/10.15420/ecr.2017:23:20